Tweets

August 20

The new study that will further fuel the controversy over pharma IP rights: https://t.co/7XzwfdGBX1

August 20

Chinese battery maker buys 100+ Google patents after being hit with US lawsuit https://t.co/PgmySL8cCu

August 20

USPTO Director Iancu, who has spoken of a "perception problem" at the PTAB, will soon have the opportunity to appoi… https://t.co/ogONUYQfv9

Blog

20 Aug 2018
Analysis Size of drug patent thickets highlighted by report, amidst intense pharma IP scrutiny

A recent report sheds new light on the patent estates protecting the US’s best-selling drugs. Revealing that over 100 applications are made on average for patents relating to blockbuster drugs, with dozens of assets being granted, the study makes plain the scale of the legal challenge facing many biosimilar producers seeking to launch their products. Released at a time of intense...

20 Aug 2018
Analysis Chinese battery maker picks up 100+ patents from Google amid IP fight with LG Chem

Recent USPTO assignments data shows the first known third-party IP acquisition by Amperex Technology Limited (ATL), a Hong Kong-based maker of lithium-ion batteries. According to the filing, Alphabet unit Google dealt 139 former Motorola assets to the company after first advertising them for sale back in 2015. IAM readers may remember ATL from a story we published last year on the...

17 Aug 2018
Analysis Exit of PTAB chief judge gives Iancu further opportunity to put his own imprint on agency leadership

The news that David Ruschke, chief judge of the Patent Trial and Appeal Board (PTAB), is leaving his role to take up a new position at the USPTO took much of the DC patent community by surprise. After the move was disclosed in a town hall meeting on Tuesday and a memo from Director Iancu was circulated internally, PTAB practitioners started to pick up on events and by that evening it had hit...

Explore the current issue

Dissecting TCL v Ericsson – what went wrong?

Ericsson has a world-class portfolio of cellular SEPs which it is keen to license on FRAND terms, but the long-awaited decision of a California court in a case involving the Swedish company and TCL may not have correctly valued the portfolio

The world's leading patent professionals

IAM Patent 1000 2018

The definitive ‘go-to’ resource for those seeking legal patent expertise, which identifies the leading lights in 70 jurisdictions globally.

View the 2018 rankings

The world's leading IP strategists

IAM Strategy 300

A directory of individuals identified following a detailed research process as global leaders in providing IP value creation expertise to rights owners.

Visit site
IAM Market
Market intelligence

Market intelligence

Annual IAM supplements and management reports that take an in-depth look at specific areas of IP value creation concern and opportunity.

Visit site
IPBC

IPBC

Unique in the global IP marketplace, IPBC events bring together corporate leaders, aggregators, investors and other intermediaries to discuss key issues, network and do deals.

Visit site
IP Hall of Fame

IP Hall of Fame

A project designed to recognise the outstanding contributions that individual men and women have made towards the creation of today’s global IP system.

Visit site
Upcoming event

Upcoming event

Patent Licensing 2018
September 18 - San Francisco 

An indispensable insight into the key domestic U.S. and global licensing trends.

View all events
Subscribe

Subscribe

IAM is a unique publication which focuses on the many ways in which intellectual property and intangible assets can be used to create corporate value.

Subscribe now
International reports

International reports

Weekly updates from IAM’s team of international correspondents looking at recent developments in IP law and practice, business and finance.

Visit site
;